BDBM453318 BDBM553824::US10730826, Compound 18a

SMILES NCCCCC(NC(=O)C1CCCC1)C(=O)COC(C(F)(F)F)C(F)(F)F

InChI Key InChIKey=JMYIBZJMKVECHO-UHFFFAOYSA-N

Data  18 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 18 hits for monomerid = 453318   

TargetLys-gingipain(Porphyromonas gingivalis)
Cortexyme

US Patent
LigandPNGBDBM453318(US10730826, Compound 18a | BDBM553824)
Affinity DataIC50: 0.5nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of lysine gingipain (Kgp) were measured in a fluorogenic assay similar t...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetCathepsin S(Human)
Cortexyme

US Patent
LigandPNGBDBM453318(US10730826, Compound 18a | BDBM553824)
Affinity DataIC50: 1.00E+4nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of cathepsins B, H, K, L, and S were measured in similar assays. Boc-Leu...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetCathepsin L2(Human)
Cortexyme

US Patent
LigandPNGBDBM453318(US10730826, Compound 18a | BDBM553824)
Affinity DataIC50: 1.00E+4nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of cathepsins B, H, K, L, and S were measured in similar assays. Boc-Leu...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetProcathepsin L(Human)
Cortexyme

US Patent
LigandPNGBDBM453318(US10730826, Compound 18a | BDBM553824)
Affinity DataIC50: 1.00E+4nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of cathepsins B, H, K, L, and S were measured in similar assays. Boc-Leu...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetCathepsin F(Human)
Cortexyme

US Patent
LigandPNGBDBM453318(US10730826, Compound 18a | BDBM553824)
Affinity DataIC50: 1.00E+4nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of cathepsins B, H, K, L, and S were measured in similar assays. Boc-Leu...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetCathepsin B(Human)
Cortexyme

US Patent
LigandPNGBDBM453318(US10730826, Compound 18a | BDBM553824)
Affinity DataIC50: 1.00E+4nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of cathepsins B, H, K, L, and S were measured in similar assays. Boc-Leu...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetPro-cathepsin H(Human)
Cortexyme

US Patent
LigandPNGBDBM453318(US10730826, Compound 18a | BDBM553824)
Affinity DataIC50: 1.00E+4nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of cathepsins B, H, K, L, and S were measured in similar assays. Boc-Leu...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetCathepsin K(Human)
Cortexyme

US Patent
LigandPNGBDBM453318(US10730826, Compound 18a | BDBM553824)
Affinity DataIC50: 1.00E+4nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of cathepsins B, H, K, L, and S were measured in similar assays. Boc-Leu...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetLys-gingipain(Porphyromonas gingivalis)
Cortexyme

US Patent
LigandPNGBDBM453318(US10730826, Compound 18a | BDBM553824)
Affinity DataIC50: 0.5nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of lysine gingipain (Kgp) were measured in a fluorogenic assay similar t...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetLys-gingipain W83(Porphyromonas gingivalis)
Cortexyme

US Patent
LigandPNGBDBM453318(US10730826, Compound 18a | BDBM553824)
Affinity DataIC50: 0.5nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of lysine gingipain were measured in a fluorogenic assay similar to thos...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetCathepsin S(Human)
Cortexyme

US Patent
LigandPNGBDBM453318(US10730826, Compound 18a | BDBM553824)
Affinity DataIC50: 1.00E+4nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of lysine gingipain were measured in a fluorogenic assay similar to thos...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetCathepsin L2(Human)
Cortexyme

US Patent
LigandPNGBDBM453318(US10730826, Compound 18a | BDBM553824)
Affinity DataIC50: 1.00E+4nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of lysine gingipain were measured in a fluorogenic assay similar to thos...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetProcathepsin L(Human)
Cortexyme

US Patent
LigandPNGBDBM453318(US10730826, Compound 18a | BDBM553824)
Affinity DataIC50: 1.00E+4nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of lysine gingipain were measured in a fluorogenic assay similar to thos...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetCathepsin F(Human)
Cortexyme

US Patent
LigandPNGBDBM453318(US10730826, Compound 18a | BDBM553824)
Affinity DataIC50: 1.00E+4nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of lysine gingipain were measured in a fluorogenic assay similar to thos...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetCathepsin B(Human)
Cortexyme

US Patent
LigandPNGBDBM453318(US10730826, Compound 18a | BDBM553824)
Affinity DataIC50: 1.00E+4nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of lysine gingipain were measured in a fluorogenic assay similar to thos...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetPro-cathepsin H(Human)
Cortexyme

US Patent
LigandPNGBDBM453318(US10730826, Compound 18a | BDBM553824)
Affinity DataIC50: 1.00E+4nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of lysine gingipain were measured in a fluorogenic assay similar to thos...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetCathepsin K(Human)
Cortexyme

US Patent
LigandPNGBDBM453318(US10730826, Compound 18a | BDBM553824)
Affinity DataIC50: 1.00E+4nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of lysine gingipain were measured in a fluorogenic assay similar to thos...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetLys-gingipain W83(Porphyromonas gingivalis)
Cortexyme

US Patent
LigandPNGBDBM453318(US10730826, Compound 18a | BDBM553824)
Affinity DataIC50: 0.5nMAssay Description:The capacities of compounds of the present invention to inhibit the activity of lysine gingipain were measured in a fluorogenic assay similar to thos...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent